Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Faiza Rharbaoui

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2009
Intranasal immunization promotes th17 immune responsesBeata M Zygmunt, Faiza Rharbaoui, Lothar Groebe, et al.
Frontiers in Immunology|February 3, 2016
Tregalizumab - A Monoclonal Antibody to Target Regulatory T CellsMartin König, Faiza Rharbaoui, Silke Aigner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2005
Characterization of a B220+ lymphoid cell subpopulation with immune modulatory functions in nasal-associated lymphoid tissuesFaiza Rharbaoui, Dunja Bruder, Melita Vidakovic, et al.
Infection and Immunity|November 24, 2004
The Mycoplasma-derived macrophage-activating 2-kilodalton lipopeptide triggers global immune activation on nasal mucosa-associated lymphoid tissuesFaiza Rharbaoui, Astrid Westendorf, Claudia Link, et al.
Microbes and Infection|June 24, 2006
An SopB-mediated immune escape mechanism of Salmonella enterica can be subverted to optimize the performance of live attenuated vaccine carrier strainsClaudia Link, Thomas Ebensen, Lothar Ständner, et al.
Infection and Immunity|September 14, 2002
Characterization of a novel intracellularly activated gene from Salmonella enterica serovar typhiHolger Basso, Faiza Rharbaoui, Lothar H Staendner, et al.
European Journal of Immunology|October 2, 2002
The Mycoplasma-derived lipopeptide MALP-2 is a potent mucosal adjuvantFaiza Rharbaoui, Birgit Drabner, Stefan Borsutzky, et al.
Clinical & Translational Immunology|January 17, 2017
High thioredoxin-1 levels in rheumatoid arthritis patients diminish binding and signalling of the monoclonal antibody TregalizumabKatharina Heim, Benjamin Dälken, Stefanie Faust, et al.
Clinical Pharmacology and Therapeutics|March 31, 2025
First-in-Human Single and Multiple Ascending Dose Studies of Balinatunfib, a Small Molecule Inhibitor of TNFR1 Signaling in Healthy ParticipantsNassr Nassr, Faiza Rharbaoui, Dietmar Weitz, et al.
European Journal of Immunology|June 5, 2003
Efficient mucosal delivery of the HIV-1 Tat protein using the synthetic lipopeptide MALP-2 as adjuvantStefan Borsutzky, Valeria Fiorelli, Thomas Ebensen, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2009
Intranasal immunization promotes th17 immune responsesBeata M Zygmunt, Faiza Rharbaoui, Lothar Groebe, et al.
Frontiers in Immunology|February 3, 2016
Tregalizumab - A Monoclonal Antibody to Target Regulatory T CellsMartin König, Faiza Rharbaoui, Silke Aigner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2005
Characterization of a B220+ lymphoid cell subpopulation with immune modulatory functions in nasal-associated lymphoid tissuesFaiza Rharbaoui, Dunja Bruder, Melita Vidakovic, et al.
Infection and Immunity|November 24, 2004
The Mycoplasma-derived macrophage-activating 2-kilodalton lipopeptide triggers global immune activation on nasal mucosa-associated lymphoid tissuesFaiza Rharbaoui, Astrid Westendorf, Claudia Link, et al.
Microbes and Infection|June 24, 2006
An SopB-mediated immune escape mechanism of Salmonella enterica can be subverted to optimize the performance of live attenuated vaccine carrier strainsClaudia Link, Thomas Ebensen, Lothar Ständner, et al.
Infection and Immunity|September 14, 2002
Characterization of a novel intracellularly activated gene from Salmonella enterica serovar typhiHolger Basso, Faiza Rharbaoui, Lothar H Staendner, et al.
European Journal of Immunology|October 2, 2002
The Mycoplasma-derived lipopeptide MALP-2 is a potent mucosal adjuvantFaiza Rharbaoui, Birgit Drabner, Stefan Borsutzky, et al.
Clinical & Translational Immunology|January 17, 2017
High thioredoxin-1 levels in rheumatoid arthritis patients diminish binding and signalling of the monoclonal antibody TregalizumabKatharina Heim, Benjamin Dälken, Stefanie Faust, et al.
Clinical Pharmacology and Therapeutics|March 31, 2025
First-in-Human Single and Multiple Ascending Dose Studies of Balinatunfib, a Small Molecule Inhibitor of TNFR1 Signaling in Healthy ParticipantsNassr Nassr, Faiza Rharbaoui, Dietmar Weitz, et al.
European Journal of Immunology|June 5, 2003
Efficient mucosal delivery of the HIV-1 Tat protein using the synthetic lipopeptide MALP-2 as adjuvantStefan Borsutzky, Valeria Fiorelli, Thomas Ebensen, et al.
Pageof 2